Medicalgorithmics S.A. (WSE: MDG)
Poland
· Delayed Price · Currency is PLN 24.40
+0.70 (2.95%)
Sep 27, 2024, 5:00 PM CET
Medicalgorithmics Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 38.83 | 43.1 | 62.72 | 48.35 | 111.73 | 173.87 | Upgrade
|
| Revenue Growth (YoY) | -36.45% | -31.28% | 29.72% | -56.73% | -35.74% | -12.81% | Upgrade
|
| Cost of Revenue | 27.51 | 26.15 | 29.52 | 22.84 | 100.44 | 111.94 | Upgrade
|
| Gross Profit | 11.32 | 16.95 | 33.2 | 25.51 | 11.29 | 61.93 | Upgrade
|
| Selling, General & Admin | 14.49 | 13.36 | 12.22 | 8.7 | 29.88 | 36.11 | Upgrade
|
| Other Operating Expenses | 1.28 | 1.51 | 1.01 | 0.53 | 3.98 | 7.18 | Upgrade
|
| Operating Expenses | 18.1 | 17.23 | 17.24 | 13.41 | 49.75 | 62.01 | Upgrade
|
| Operating Income | -6.78 | -0.28 | 15.96 | 12.1 | -38.46 | -0.08 | Upgrade
|
| Interest Expense | -0.07 | -0.11 | -0.27 | -0.61 | -0.96 | -2.08 | Upgrade
|
| Interest & Investment Income | 0.86 | 0.75 | - | 0.24 | 0.18 | 0.08 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.4 | -1.35 | 8.08 | 2.9 | -1.6 | -0.34 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.1 | 0.04 | 0.24 | 0.11 | -0.06 | -0.23 | Upgrade
|
| EBT Excluding Unusual Items | -7.28 | -0.95 | 24.01 | 14.73 | -40.9 | -2.65 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.14 | Upgrade
|
| Asset Writedown | 0.71 | 0.71 | - | -21.74 | -3.11 | - | Upgrade
|
| Other Unusual Items | - | - | 1.26 | - | 4.06 | 0.14 | Upgrade
|
| Pretax Income | -6.56 | -0.24 | 25.26 | -7.01 | -39.95 | -2.66 | Upgrade
|
| Income Tax Expense | -0.46 | 0.34 | -0.22 | -0.44 | -12.27 | -2.36 | Upgrade
|
| Earnings From Continuing Operations | -6.11 | -0.58 | 25.48 | -6.57 | -27.68 | -0.3 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -37.34 | -174.07 | - | - | Upgrade
|
| Net Income to Company | -6.11 | -0.58 | -11.86 | -180.64 | -27.68 | -0.3 | Upgrade
|
| Minority Interest in Earnings | 0 | - | - | - | 14.76 | 4.58 | Upgrade
|
| Net Income | -6.1 | -0.58 | -11.86 | -180.64 | -12.92 | 4.28 | Upgrade
|
| Net Income to Common | -6.1 | -0.58 | -11.86 | -180.64 | -12.92 | 4.28 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -70.32% | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 6 | 5 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 6 | 5 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | 43.31% | 74.58% | 25.38% | 9.88% | 14.72% | - | Upgrade
|
| EPS (Basic) | -0.61 | -0.06 | -2.08 | -39.73 | -3.12 | 1.19 | Upgrade
|
| EPS (Diluted) | -0.61 | -0.06 | -2.08 | -39.73 | -3.12 | 1.19 | Upgrade
|
| EPS Growth | - | - | - | - | - | -70.32% | Upgrade
|
| Free Cash Flow | -8.79 | -0.31 | 6.33 | -16.39 | -4.37 | 9.68 | Upgrade
|
| Free Cash Flow Per Share | -0.88 | -0.03 | 1.11 | -3.60 | -1.06 | 2.68 | Upgrade
|
| Gross Margin | 29.16% | 39.34% | 52.94% | 52.76% | 10.11% | 35.62% | Upgrade
|
| Operating Margin | -17.46% | -0.65% | 25.44% | 25.03% | -34.42% | -0.05% | Upgrade
|
| Profit Margin | -15.72% | -1.34% | -18.91% | -373.61% | -11.56% | 2.46% | Upgrade
|
| Free Cash Flow Margin | -22.63% | -0.71% | 10.09% | -33.90% | -3.91% | 5.57% | Upgrade
|
| EBITDA | -7.05 | 0.14 | 16.6 | 22.05 | -28.61 | 11.08 | Upgrade
|
| EBITDA Margin | -18.15% | 0.33% | 26.47% | 45.61% | -25.60% | 6.37% | Upgrade
|
| D&A For EBITDA | -0.27 | 0.42 | 0.64 | 9.95 | 9.85 | 11.16 | Upgrade
|
| EBIT | -6.78 | -0.28 | 15.96 | 12.1 | -38.46 | -0.08 | Upgrade
|
| EBIT Margin | -17.46% | -0.65% | 25.44% | 25.03% | -34.42% | -0.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.